The HCCO plays a crucial role in helping Johnson & Johnson (J&J) to achieve high performance with high integrity: Leading the HCC Program for J&J MedTech and Vision Japan, to ensure business practices and activities are
SUMMARY Responsible and accountable for Medical Affairs strategy of Urological cancer products C ollaborates with internal and external stakeholders including key opinion leaders to develop and implement the overall M edical Affairs strategy for product lifecycle align ed with
RESPONSIBILITIES/PRINCIPAL DUTIES: The Manager, IPN (Immunology, PAH and Neuroscience) Communication & Public Affairs, Janssen Japan is an important leadership role in our Japan Pharmaceutical Communication & Public Affairs (CPA) team responsible for our end-to-end communication strategy for our
Position Purpose Develop and implement the business strategy for Immunology portfolio, with both short-term and long-term business objectives Oversee and lead all marketing and sales plans to achieve the business objectives within policies and guidelines as
Position Purpose Maximize urothelial cancer business managing in-line prostate cancer product and developing bladder cancer portfolio(New products) Develop synergistic strategy of PC and BC to deliver holistic approach Deliver the agreed forecast budget and business plan
•Position Purpose •Develop and deliver strategies to give our company customer facing teams a competitive edge with personalized engagement as well as data-driven insights using advanced commercial processes, systems and tools •Key Responsibility Areas •Establish the
Position Purpose Develop and implement a business strategy for Janssen Japans introduction into the highly competitive Lung Cancer market with both short term and long-term business objectives Oversee and lead all marketing and sales plans to
The Associate Director of Medical Affairs, Multiple Myeloma (MM) Medical Science Liaison (MSL) will be responsible for organizational operation and people management of the MM MSL group, reporting to the Director of Hematology, Medical Affairs Japan. A strong insight into the MM disease
